Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Stomatitis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Gemcitabine 4Cisplatin 4Rituximab 2Fluorouracil 2Everolimus 2tislelizumab 1phosphorylethanolamine 1parsaclisib 1human papillomavirus vaccine, L1 type 16, 18 1famitinib 1dalpiciclib 1Zinc Sulfate 1Zinc 1Vitamin B 6 1Tamoxifen 1Sunitinib 1Sorafenib 1Radiotherapy, Adjuvant 1Pyridoxine 1Proton Pump Inhibitors 1Prednisone 1Platelet Transfusion 1Photochemotherapy 1Pemetrexed 1Patient Portals 1Paclitaxel 1Oxaliplatin 1Neoadjuvant Therapy 1N-hydroxy-4-acetylaminostilbene 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × OTHER_GOV × Mannitol × Clear all
NCT04321850 2020-08-04

Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.

National Institute of Pediatrics, Mexico

Phase NA Terminated
21 enrolled
LymphoidOther hematologic neoplasm

Stomatitis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡